Chapter 9: Chronic Pain and Its Treatment

Loading audio…

ⓘ This audio and summary are simplified educational interpretations and are not a substitute for the original text.

If there is an issue with this chapter, please let us know → Contact Us

Nociception involves primary afferent neurons transmitting danger signals from peripheral tissues through the spinal dorsal horn and ascending via two parallel routes: the spinothalamic tract carries sensory and discriminatory information to the somatosensory cortex for localization and intensity perception, while spinobulbar pathways project to limbic structures and convey the emotional and affective dimensions of pain experience. Chronic pain frequently transitions from peripheral tissue damage to centralized neuropathic pain, a state arising from nervous system dysfunction or injury characterized by maladaptive neuroplastic changes termed central sensitization. Sensitization can occur at the spinal cord level, producing phenomena such as allodynia and hyperalgesia seen in conditions like diabetic neuropathy and postherpetic neuralgia, or at higher brain centers including the thalamus and cortex, where the brain essentially encodes and maintains the pain signal independent of peripheral input, as observed in fibromyalgia and chronic widespread pain syndromes. Research reveals that chronic pain conditions correlate with gray matter volume reductions in regions like the dorsolateral prefrontal cortex and thalamus, potentially explaining cognitive symptoms such as fibro-fog. Treatment targets sensitized pain circuits using two primary drug classes. Serotonin-norepinephrine reuptake inhibitors potentiate the brain's endogenous descending inhibitory pathways originating in the periaqueductal gray, which use serotonin and norepinephrine to suppress nociceptive signaling in the dorsal horn. Alpha-two-delta ligands including gabapentin and pregabalin bind the alpha-two-delta subunit of presynaptic voltage-gated calcium channels in the dorsal horn and higher pain centers, reducing calcium entry and decreasing excessive glutamate release from hyperactive pain neurons. The chapter emphasizes that early aggressive treatment is warranted given the potential for central sensitization to become permanently established, positioning chronic pain as a psychiatric vital sign requiring prompt intervention to prevent progression and achieve full symptom resolution.